Back to mobile site

More on CNTX

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (10.0 Score)

Upcoming Events

- Earnings (8/12/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Context Therapeutics (NQ:CNTX)
Delayed: 0.63 --0 (-0%)
Prev. Close $0.63  
Open$0.63 
52 Wk High$ 
52 Wk Low$ 
Day High$0.70 
Day Low$0.61 
P/E N/A  
EPS$ 
Volume3,963,269 

Friends, Peers and Foes (?): SKYE, NEOG, BCAB, IMNM, ONCY (more...)

Jun 16, 2026 09:55 AM Context Therapeutics (CNTX) PT Lowered to $4 at Maxim Group
Jun 15, 2026 09:19 AM Form 8-K Context Therapeutics For: Jun 15
Jun 15, 2026 06:30 AM Context Therapeutics reports interim phase 1 trial results for CTIM-76
Jun 15, 2026 06:30 AM Context Therapeutics Announces Positive Interim Efficacy and Safety Results from Ongoing Phase 1 Clinical Trial for CTIM-76
Jun 9, 2026 04:10 PM Context Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
May 27, 2026 07:30 AM Context Therapeutics to Present at the Jefferies Global Healthcare Conference
May 18, 2026 06:47 AM Form 8-K Context Therapeutics For: May 14
May 18, 2026 06:45 AM Context Therapeutics amends BioAtla license deal for CT-202 drug
May 18, 2026 06:45 AM Context Therapeutics Enters into License Agreement Amendment with BioAtla for CT-202
May 15, 2026 08:55 AM Form SCHEDULE 13G/A Context Therapeutics Filed by: GREAT POINT PARTNERS LLC
View All Articles

Entities mentioned with CNTX

View All Entities